|
1
|
Bahar AA and Ren D: Antimicrobial
peptides. Pharmaceuticals (Basel). 6:1543–1575. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang LJ and Gallo RL: Antimicrobial
peptides. Curr Biol. 26:R14–R19. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hoffmann J and Akira S: Innate immunity.
Curr Opin Immunol. 25:1–3. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jones JD, Vance RE and Dangl JL:
Intracellular innate immune surveillance devices in plants and
animals. Science. 354(aaf6395)2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Jenssen H, Hamill P and Hancock RE:
Peptide antimicrobial agents. Clin Microbiol Rev. 19:491–511.
2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lei J, Sun L, Huang S, Zhu C, Li P, He J,
Mackey V, Coy DH and He Q: The antimicrobial peptides and their
potential clinical applications. Am J Transl Res. 11:3919–3931.
2019.PubMed/NCBI
|
|
7
|
Chen Y, Guarnieri MT, Vasil AI, Vasil ML,
Mant CT and Hodges RS: Role of peptide hydrophobicity in the
mechanism of action of alpha-helical antimicrobial peptides.
Antimicrob Agents Chemother. 51:1398–1406. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Prasad SV, Fiedoruk K, Daniluk T, Piktel E
and Bucki R: Expression and function of host defense peptides at
inflammation sites. Int J Mol Sci. 21(104)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Weinberg A, Jin G, Sieg S and McCormick
TS: The yin and yang of human beta-defensins in health and disease.
Front Immunol. 3(294)2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pazgier M, Hoover DM, Yang D, Lu W and
Lubkowski J: Human beta-defensins. Cell Mol Life Sci. 63:1294–1313.
2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Marcinkiewicz M and Majewski S: The role
of antimicrobial peptides in chronic inflammatory skin diseases.
Postepy Dermatol Alergol. 33:6–12. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kościuczuk EM, Lisowski P, Jarczak J,
Strzałkowska N, Jóźwik A, Horbańczuk J, Krzyżewski J, Zwierzchowski
L and Bagnicka E: Cathelicidins: Family of antimicrobial peptides.
A review. Mol Biol Rep. 39:10957–10970. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vandamme D, Landuyt B, Luyten W and
Schoofs L: A comprehensive summary of LL-37, the factotum human
cathelicidin peptide. Cell Immunol. 280:22–35. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Agier J, Efenberger M and
Brzezińska-Błaszczyk E: Cathelicidin impact on inflammatory cells.
Cent Eur J Immunol. 40:225–235. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Agier J, Brzezińska-Błaszczyk E,
Żelechowska P, Wiktorska M, Pietrzak J and Różalska S: Cathelicidin
LL-37 affects surface and intracellular toll-like receptor
expression in tissue mast cells. J Immunol Res.
2018(7357162)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lande R, Botti E, Jandus C, Dojcinovic D,
Fanelli G, Conrad C, Chamilos G, Feldmeyer L, Marinari B, Chon S,
et al: The antimicrobial peptide LL37 is a T-cell autoantigen in
psoriasis. Nat Commun. 5(5621)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chen X, Zou X, Qi G, Tang Y, Guo Y, Si J
and Liang L: Roles and mechanisms of human cathelicidin LL-37 in
cancer. Cell Physiol Biochem. 47:1060–1073. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Eckert RL, Broome AM, Ruse M, Robinson N,
Ryan D and Lee K: S100 proteins in the epidermis. J Invest
Dermatol. 123:23–33. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Brodersen DE, Etzerodt M, Madsen P, Celis
JE, Thøgersen HC, Nyborg J and Kjeldgaard M: EF-hands at atomic
resolution: The structure of human psoriasin (S100A7) solved by MAD
phasing. Structure. 6:477–489. 1998.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lee KC and Eckert RL: S100A7
(psoriasin)-mechanism of antibacterial action in wounds. J Invest
Dermatol. 127:945–957. 2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Son ED, Kim HJ, Kim KH, Bin BH, Bae IH,
Lim KM, Yu SJ, Cho EG and Lee TR: S100A7 (psoriasin) inhibits human
epidermal differentiation by enhanced IL-6 secretion through
IκB/NF-κB signalling. Exp Dermatol. 25:636–641. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hulse KA, Singh R and Chaung K: STAT3 and
NF-κB regulate S100A7 expression in human bronchial epithelial
cells. J Allergy Clin Immunol. 129(AB68)2012.
|
|
23
|
Águeda-Pinto A, Castro LFC and Esteves PJ:
The evolution of S100A7: An unusual gene expansion in myotis bats.
BMC Evol Biol. 19(102)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Nguyen TT, Niyonsaba F, Ushio H, Akiyama
T, Kiatsurayanon C, Smithrithee R, Ikeda S, Okumura K and Ogawa H:
Interleukin-36 cytokines enhance the production of host defense
peptides psoriasin and LL-37 by human keratinocytes through
activation of MAPKs and NF-κB. J Dermatol Sci. 68:63–66.
2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tian T, Li X, Hua Z, Ma J, Wu X, Liu Z,
Chen H and Cui Z: S100A7 promotes the migration, invasion and
metastasis of human cervical cancer cells through
epithelial-mesenchymal transition. Oncotarget. 8:24964–24977.
2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Becknell B and Spencer JD: A review of
ribonuclease 7's structure, regulation, and contributions to host
defense. Int J Mol Sci. 17(423)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Schwartz L, Cohen A, Thomas J and Spencer
JD: The immunomodulatory and antimicrobial properties of the
vertebrate ribonuclease a superfamily. Vaccines (Basel).
6(76)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kopfnagel V, Wagenknecht S, Brand L,
Zeitvogel J, Harder J, Hofmann K, Kleine M and Werfel T: RNase 7
downregulates TH2 cytokine production by activated human T cells.
Allergy. 72:1694–1703. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kopfnagel V, Wagenknecht S, Harder J,
Hofmann K, Kleine M, Buch A, Sodeik B and Werfel T: RNase 7
strongly promotes TLR9-mediated DNA sensing by human plasmacytoid
dendritic cells. J Invest Dermatol. 138:872–881. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Paulmann M, Arnold T, Linke D, Özdirekcan
S, Kopp A, Gutsmann T, Kalbacher H, Wanke I, Schuenemann VJ, Habeck
M, et al: Structure-activity analysis of the dermcidin-derived
peptide DCD-1L, an anionic antimicrobial peptide present in human
sweat. J Biol Chem. 287:8434–8443. 2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Schittek B: The multiple facets of
dermcidin in cell survival and host defense. J Innate Immun.
4:349–360. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Sun E, Belanger CR, Haney EF and Hancock
RE: Host defense (antimicrobial) peptides. Computational And
Systems Biol. 10:253–285. 2018.
|
|
33
|
Lee EY, Lee MW and Wong GCL: Modulation of
toll-like receptor signaling by antimicrobial peptides. Semin Cell
Dev Biol. 88:173–184. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kao CY, Chen Y, Thai P, Wachi S, Huang F,
Kim C, Harper RW and Wu R: IL-17 markedly up-regulates
beta-defensin-2 expression in human airway epithelium via JAK and
NF-kappaB signaling pathways. J Immunol. 173:3482–3491.
2004.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Schmidt N, Jin F, Lande R, Curk T, Xian W,
Lee C, Frasca L, Frenkel D, Dobnikar J, Gilliet M and Wong GC:
Liquid-crystalline ordering of antimicrobial peptide-DNA complexes
controls TLR9 activation. Nat Mater. 14:696–700. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Choi KY and Mookherjee N: Multiple
immune-modulatory functions of cathelicidin host defense peptides.
Front Immunol. 3(149)2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Boehncke WH and Schön MP: Psoriasis.
Lancet. 386:983–994. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Mahil SK, Capon F and Barker JN: Update on
psoriasis immunopathogenesis and targeted immunotherapy. Semin
Immunopathol. 38:11–27. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Gottlieb AB, Lebwohl M, Shirin S, Sherr A,
Gilleaudeau P, Singer G, Solodkina G, Grossman R, Gisoldi E,
Phillips S, et al: Anti-CD4 monoclonal antibody treatment of
moderate to severe psoriasis vulgaris: Results of a pilot,
multicenter, multiple-dose, placebo-controlled study. J Am Acad
Dermatol. 43:595–604. 2000.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Di Cesare A, Di Meglio P and Nestle FO:
The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J
Invest Dermatol. 129:1339–1350. 2009.PubMed/NCBI View Article : Google Scholar
|
